Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults

Tobacco-Related Carcinoma Clinical Trial

Official title:

The Effect of Nicotine and Tobacco Message Framing on Use Among Diverse Groups of Young Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05393869
• Other study ID #: OSU-20427
• Secondary ID: NCI-2022-02543K9
• Status: Completed
• Phase: N/A
• Start date: April 14, 2021
• Est. completion date: November 14, 2022

Study information

• Verified date: December 2023
• Source: Ohio State University Comprehensive Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.

Description:

PRIMARY OBJECTIVES:

I. Identify absolute and relative risk anti-tobacco messages that effectively communicate polytobacco risks to lesbian, gay, bisexual, transgender (LGBT) young adults.

Participants view anti-tobacco messages and rate them for perceived effectiveness and reactance.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2849
• Est. completion date: November 14, 2022
• Est. primary completion date: November 14, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Young adults (age 18-35 years)

• Live in the United States

At least 50% of the sample also:

• Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)

Related Conditions & MeSH terms

• Tobacco-Related Carcinoma

Intervention

Other:
• Health communications
Participants are assigned to view health communications with risk and efficacy statements.

Locations

Country	Name	City	State
United States	Ohio State University Comprehensive Cancer Center	Columbus	Ohio

Sponsors (2)

Lead Sponsor	Collaborator
Ohio State University Comprehensive Cancer Center	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Message Perceived Effectiveness - Persuasive Potential.	6 items measured on 5-point scale, 1 = Not at all and 5 = Very much; These messages were worth remembering.; These messages grabbed my attention.; These messages are powerful.; These messages are convincing.; These messages are meaningful.; These messages are informative.; Responses were summed and averaged to create a scale for intention to quit (range from 1 - 5).; Higher scores indicate a higher persuasive potential of the message.	Immediately post-exposure to intervention, up to 1 hour
Primary	Perceived Effectiveness - Perceived Behavioral Impact	Six items were analyzed separately, each scored on 5-point Likert scale (1=Strongly Disagree, 5=Strongly Agree); These messages will motivate CIGARETTE SMOKERS to switch to vaping.; These messages will motivate people to quit ALL smoking and vaping.; These messages will motivate NON-USERS to start vaping.; These messages will motivate NON-USERS to start smoking cigarettes.; These messages will motivate CIGARETTE SMOKERS to quit.; These messages will motivate VAPERS to quit.	Immediately post-exposure to intervention, up to 1 hour
Primary	Risk Perceptions: Absolute/Relative Risks of Cigarette vs. E-cigarette Use	On a scale from 0-10, where 0 = not at all harmful and 10 = extremely harmful now harmful are ... to your health?; combustible cigarettes; nicotine vapes; On a scale from 0-10, where 0 = much less harmful and 10 = much more harmful...; • compared to combustible cigarettes, how harmful are nicotine vapes to your health?	Immediately post-exposure to intervention, up to 1 hour
Primary	Behavioral Intentions to Use Tobacco	8-items made up two 4-pt scales (1 = definitely will not and 4 = definitely will).; Items for each scale were summed and averaged. Higher scores indicate higher likelihood of avoiding cigarettes/nicotine vapes.; How likely it is that in the next 3 months, you will refrain from...; smoking cigarettes completely and permanently?; smoking cigarettes when you get lonely?; smoking cigarettes when you are with your friends who use them?; smoking cigarettes when someone hands you a cigarette?; How likely it is that in the next 3 months, you will refrain from...; vaping nicotine completely and permanently?; vaping nicotine when you get lonely?; vaping nicotine when you are with your friends who use them?; vaping nicotine when someone hands you a vape?	Immediately post-exposure to intervention, up to 1 hour

External Links

•   The Jamesline